novartis 1 1

Tag: "novartis" at medical news

Novartis files application with FDA for Zometa

Novartis Pharmaceuticals has submitted an application to the Food and Drug Administration, seeking marketing authorization for Zometa in the treatment of bone complications associated with a broad range of tumor types. These include prostate and lung cancer, for which no bisphosphonate therapy is currently approved. The spread of cancerous cells from the original tumor to the bone, can lead to se...

Zometa [Novartis Drug] For Treatment Of Paget’s Diseas

Results of the clinical study carried out by Professor Ian Reed and his team from the University of Auckland in New Zealand has found that the drug Zometa manufactured by Novartis treats Paget’s disease// far better than the drug Actonel produced by Procter and Gamble. ....Paget's disease is a condition in which the bones breaks or becomes weak faster than the normal and the new bone replacement...

Canine Painkiller unveiled by Novartis

Novartis received approval from the Food and Drug Administration to begin marketing Deramaxx, a canine painkiller, which will be used to relieve post-operative pain in dogs. This drug being produced by a Novartis facility at Puerto Rico //is the result of a development project undertaken by Novartis Animal Health that was run for several years at veterinary clinics, colleges and its manufacturing...

Glivec the hot cancer drug from Novartis

Novartis is the world's sixth-largest drugmaker (by sales). ..Novartis was formed after merger of two Swiss companies, Sandoz Ltd. and Ciba-Geigy."Novartis ..is emerging as one of the premier powerhouses in the global pharmaceuticals industry," ..says Richard R. Stover, senior analyst with brokerage Natexis Bleichroeder Inc. ..in New York. The new cancer drug, Glivec's success led to Novartis re...

Novartis MS Drug Shows Promising Results

Data from the extension of a Phase II study to 12 months confirm the significant effects of FTY720, a novel oral medication//, for the treatment of patients with relapsing multiple sclerosis (MS). ....The data, presented at the ECTRIMS/ACTRIMS meeting in Thessalonica, Greece, showed that both patient groups taking FTY720 (1.25 mg and 5 mg) who had experienced a reduction in their annualized rela...

Bird-flu Vaccine Adjuvant Contract Goes to Novartis

Swiss-based global pharmaceutical giant Novartis bagged the contract to make a chemical that would boost the effectiveness of bird-flu vaccines. The $54.8 million contract// was finalised on Wednesday. ....The company already has more than $300 million in federal contracts to fight a possible bird-flu outbreak in humans. ....Two other firms were also awarded contracts on Wednesday by the U.S. D...

Drop Patent Petition, Activists Ask Novartis

Seeking to keep the price of a cancer drug affordable for masses, activists from several countries Monday gathered here and asked Swiss pharmaceutical major Novartis// to withdraw its case against the Indian government that has not granted patent to its anti-cancer medicine. ...."India produces affordable medicines that help millions of people both here and in many other developing countries. A...

E.U. Panel Backs Novartis' Mock-up Pandemic Flu Vaccine

Europe's main medical regulator said it has adopted a positive opinion recommending the granting of a marketing authorization for Focetria, from Novartis //AG (NVS) Vaccines and Diagnostics unit. ....Focetria is a mock-up pandemic influenza vaccine, intended for the prevention of influenza during an officially declared pandemic situation, once the pandemic viral strain has been included. It is...

Indian Court Refers Novartis Plea for Patent on Anti-cancer Drug to a Separate Board

The Madras High Court in the southern Indian state of Tamil Nadu has decided to transfer the Novartis AG’s appeal against the rejection of its patent// plea for the anti-cancer drug Glivec to the Intellectual Property Appellate Board. ....The decision could be considered a temporary setback to the pharma multinational. ..For it cannot hope for any early decision on the patent plea. The Appellat...

Novartis Gleevec Found Effective in Treating Gastro-intestinal Tumors

The US-based National Cancer Institute (NCI) has commended Novartis' anti-cancer tablet, Gleevec, as an// effective therapy for patients suffering from GISTs, metastatic gastro-intestinal tumors. ....These tumours do have a rather complicated name. They are found in the digestive system - the gastrointestinal tract. They develop from cells of connective tissues that control the movements of th...

Novartis Drug Diovan Shows Superior Benefits

Results of a Japanese study have given drug giant Novartis AG, more reasons to smile. According to the study published in The Lancet, the company’s blood pressure// drug Diovan was observed to reduce the risks of strokes and cardiovascular events by up to 40 percent. .. The study titled the Jikei Heart Study, was based on 3,000 people aged 20 to 79, with high blood pressure, ischemic heart dise...

US Court Allows Teva to Deliver Disputed Drug: Novartis

A US court has authorised Israeli generic medicines group Teva to resume deliveries of a blood pressure drug despite a patent lawsuit by Novartis, the Swiss pharmaceutical group said on Tuesday . A US federal court judge in New Jersey rejected on Monday a request from Novartis to stop Teva Pharmaceuticals from resuming shipments of generic versions of the drug, pending a trial in the case, the Sw...